definiens: means ( a ) all patents and patent applications identified inSchedule C, ( b ) all patent applications filed either from such patents, patent applications or provisionalapplications or from an application claiming priority from either of these, including divisionals, continuations, continuations - in - part, provisionals, and continued prosecution applications in any jurisdiction, ( c ) any and allpatents that have issued or in the future issue from the foregoing patent applications ( ( a ) and ( b ) ), includingutility models, petty patents and design patents and certificates of invention, ( d ) any and all extensions orrestorations by existing or future extension or restoration mechanisms, including revalidations, reissues, re - examinations and extensions ( including any supplementary protection certificates and the like ) of theforegoing patents or patent applications ( ( a ), ( b ) and ( c ) ), and ( e ) any similar rights, including so - called pipelineprotection, or any importation, revalidation, confirmation or introduction patent or registration patent or patentof additions to any such foregoing patent applications and patents . [COMPANY] ’s Second Set of Patent Rightsshall not include orphan drug rights or any other form of data or regulatory exclusivity